About Simplivia
Data last updated:
Simplivia is a company based in Qiryat Shemona (Israel) founded in 2019. It operates as a B2B. Simplivia has completed 1 acquisition, including Novamed. Simplivia offers products and services including Chemfort® and Tevadaptor®. Simplivia operates in a competitive market with competitors including Equashield, ICU Medical, Carmel Pharma and Corvida Medical, among others.
- Headquarter Qiryat Shemona, Israel
- SectorsHealthcare
- PhoneLocked
- WebsiteLocked
- SocialLocked
- Legal Name Simplivia Healthcare Ltd
- Annual RevenueNot available
- Net ProfitNot available
- EBITDANot available
- Latest Funding RoundNot available
- InvestorsNot available
- Employee CountNot available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Simplivia
Simplivia offers a comprehensive portfolio of products and services, including Chemfort® and Tevadaptor®.
Provides safe transfer of hazardous drugs for healthcare use.
Enables secure drug handling with FDA clearance.
People of Simplivia
Unlock access to complete
Funding Insights of Simplivia
Detailed funding history for Simplivia
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Simplivia
Simplivia has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Novamed.
Investment portfolio details for Simplivia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
Proprietary immunochromatographic diagnostic systems are developed for infection detection. | Locked | Locked | 1995 | Locked |
Complete acquisition details for Simplivia
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Simplivia
Detailed financials for Simplivia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Simplivia Comparisons
Peer comparison for Simplivia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Simplivia
Simplivia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Equashield, ICU Medical, Carmel Pharma and Corvida Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked | Closed-system transfer devices for hazardous drug handling are developed. | |
| Locked | Locked | Locked | Drug and Infusion delivery devices | |
| Locked | Locked | Locked | Closed-system transfer devices are produced for safe hazardous drug handling. | |
| Locked | Locked | Locked | Closed system transfer device for safe administration of hazardous drugs |
Detailed competitors of Simplivia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Simplivia
Complete news archive for Simplivia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Simplivia
Simplivia was founded in 2019.
Simplivia is headquartered in Qiryat Shemona, Israel. It is registered at Qiryat Shemona, Northern District, Israel.
Simplivia is a global leader in designing and manufacturing innovative drug-delivery solutions, focusing on closed system transfer devices (CSTDs). These products reduce the risk of hazardous drug exposure for healthcare professionals, including pharmacists and nurses, by providing sealed, user-friendly tools. The company operates worldwide, serving hospitals, veterinary settings, and oncology centers through advanced, cost-efficient technologies that ensure safety during drug preparation and administration.
Simplivia's top competitors include Equashield, ICU Medical and Carmel Pharma.
Simplivia offers Chemfort® and Tevadaptor®.
Simplivia has made 1 acquisition, including Novamed.